1-13 of 13
Tobias A.W. Holderried
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Vaccination Using an Allogeneic Leukemia-Derived Dendritic Cell Vaccine, Maintains and Improves Frequencies of Circulating Antigen Presenting Dendritic Cells Correlating with Relapse Free and Overall Survival in AML Patients

Hester Van Zeeburg, Eva Wagner Drouet, Uwe Platzbecker, Tobias A.W. Holderried, Catharina Van Elssen, Aristoteles Giagounidis, Soren Lehmann, Jeroen Rovers, Bjorn T. Gjertsen, Arjan A. van de Loosdrecht
Journal: Blood
Blood (2023) 142 (Supplement 1): 2957.
https://doi.org/10.1182/blood-2023-188573
Published: 2023
Journal Articles

Induction of Cellular and Humoral Immune Responses Is Associated with Durable Remissions in MRD+ AML-Patients after Maintenance Treatment with an Allogeneic Leukemia-Derived Dendritic Cell Vaccine

Arjan A. van de Loosdrecht, Eva Wagner Drouet, Uwe Platzbecker, Tobias A.W. Holderried, Catharina Van Elssen, Aristoteles Giagounidis, Soren Lehmann, Hester Van Zeeburg, Jeroen Rovers, Bjorn T. Gjertsen
Journal: Blood
Blood (2023) 142 (Supplement 1): 769.
https://doi.org/10.1182/blood-2023-185532
Published: 2023
Journal Articles

Induction of a Systemic Immune Response during Use of an Allogenic Leukemia-Derived Dendritic Cell Vaccine in MRD+ AML Patients Correlates with Clinical Response and MRD Conversion

Arjan A. Van de Loosdrecht, Jacqueline Cloos, Eva-Maria Wagner-Drouet, Uwe Platzbecker, Tobias A.W. Holderried, Catharina van Elssen, Aristoteles Giagounidis, Marij J.P. Welters, Sjoerd H. van der Burg, Hester J.T. van Zeeburg, Jeroen Rovers, Bjorn T. Gjertsen
Journal: Blood
Blood (2022) 140 (Supplement 1): 3410–3411.
https://doi.org/10.1182/blood-2022-163116
Published: 2022
Journal Articles

The Potential of E-Health in Patients after Allogeneic Stem Cell Transplantation

Friederike Schmitz, Charlotte Neuerburg, Martin Schumacher, Udo Holtick, Edgar Jost, Guido Kobbe, Ben-Niklas Bärmann, Marie-Therese Schmitz, Matthias Schmid, Peter Brossart, Martin Holderried, Tobias A.W. Holderried
Journal: Blood
Blood (2022) 140 (Supplement 1): 7966–7967.
https://doi.org/10.1182/blood-2022-160320
Published: 2022
Journal Articles

Use of an Allogeneic Leukemia-Derived Dendritic Cell Vaccine in MRD+ AML-Patients Results in MRD Conversion, Improved Relapse-Free Survival and Vaccine Induced Immune Responses to Tumor Antigens

Arjan A. Van de Loosdrecht, Jacqueline Cloos, Eva-Maria Wagner-Drouet, Uwe Platzbecker, Tobias A.W. Holderried, Catharina van Elssen, Aristoteles Giagounidis, Sören Lehmann, Hester J.T. van Zeeburg, Jeroen Rovers, Bjorn T. Gjertsen
Journal: Blood
Blood (2022) 140 (Supplement 1): 1714–1715.
https://doi.org/10.1182/blood-2022-162169
Published: 2022
Journal Articles

Human CD8 + Treg after Allogeneic Stem-Cell Transplantation

Tobias A.W. Holderried, MD, Pia Sauerborn, Hye-Jung Kim, PhD, Harvey Cantor, MD, Dominik Wolf, MD, Peter Brossart, MD
Journal: Blood
Blood (2016) 128 (22): 2243.
https://doi.org/10.1182/blood.V128.22.2243.2243
Published: 2016
Journal Articles

CD8 + Treg - From Mouse To Man

Tobias A.W. Holderried, MD, Hye-Jung Kim, PhD, Philipp A Lang, MD, PhD, Harvey Cantor, MD
Journal: Blood
Blood (2013) 122 (21): 3474.
https://doi.org/10.1182/blood.V122.21.3474.3474
Published: 2013
Journal Articles

Releasing CD8 + Treg Mediated Suppresssion Enhances Anti-Viral Immune Response

Tobias A.W. Holderried, MD, Hye-Jung Kim, PhD, Philipp A Lang, MD, PhD, Harvey Cantor, MD
Journal: Blood
Blood (2013) 122 (21): 2280.
https://doi.org/10.1182/blood.V122.21.2280.2280
Published: 2013
Journal Articles

Immunotherapy With RNA Vaccination Coding For TAA In Renal Cell Carcinoma: Update On Immunological Responses and Correlation With Survival

Susanne M Rittig, MD, Maik Häntschel, MD, Katrin J Weimer, MD, Annkristin Heine, MD, Martin R Müller, MD, PhD, Wolfram Brugger, MD, Marius Horger, MD, Olga Maksimovic, MD, Arnulf Stenzl, MD, Ingmar Hoerr, Hans-Georg Rammensee, Tobias A.W. Holderried, MD, Lothar Kanz, MD, Steve Pascolo, Peter Brossart, MD
Journal: Blood
Blood (2013) 122 (21): 1040.
https://doi.org/10.1182/blood.V122.21.1040.1040
Published: 2013
Journal Articles

A Mouse Model for Immunotherapeutic Reversal of Leukemia-Induced T Cell Dysfunction

Alan G. Ramsay, PhD, Gullu Gorgun, PhD, Tobias A.W. Holderried, David Zahrieh, MS, Fenglong Liu, PhD, John Quackenbush, PhD, Carlo M. Croce, MD, John G. Gribben, MD, DSc
Journal: Blood
Blood (2008) 112 (11): 30.
https://doi.org/10.1182/blood.V112.11.30.30
Published: 2008
Journal Articles

CLL Cells in TCL1 Transgenic Mice Induce Similar Defects in CD4 and CD8 T Cells to Those Observed in Patients with CLL.

Gullu Gorgun, PhD, Tobias A.W. Holderried, Rifca Ledieu, MD, David Zahrieh, MS, John G. Gribben, MD,DSc.
Journal: Blood
Blood (2005) 106 (11): 50.
https://doi.org/10.1182/blood.V106.11.50.50
Published: 2005
Journal Articles

Cell Contact with CLL Cells Induces Defects in T Cell Differentiation and Effector Pathways: Impact of Silencing Specific Cytokine Production.

Tobias A.W. Holderried, Gullu Gorgun, PhD, John G. Gribben, MD DSc
Journal: Blood
Blood (2004) 104 (11): 955.
https://doi.org/10.1182/blood.V104.11.955.955
Published: 2004
Journal Articles

Gene Expression Profiling Identifies Similar CD4 + and CD8 + T Cell Defects in TCL1 Transgenic Mice after Development of CLL to Those Observed in Patients with CLL.

Vassiliki Rizouli, MD, David Zahrieh, MS, Gullu Gorgun, PhD, Tobias A.W. Holderried, Carlo Croce, MD, John G. Gribben, MD, DSc
Journal: Blood
Blood (2004) 104 (11): 180.
https://doi.org/10.1182/blood.V104.11.180.180
Published: 2004